Improving Care for infants with Neonatal Abstinence Syndrome
Project Description: We would like to start a QI initiative working with a multidisciplinary group to provide excellent, high-value care to infants affected by maternal opioid use in utero and decrease unnecessary use of opioids after birth for treatment of neonatal abstinence syndrome (NAS). We are in the planning stage, but hope to assemble a multidisciplinary team of doctors from Pediatric Hospital Medicine, Newborn Nursery, Obstetrics, as well as nurses from similar units and in the community, QI leaders, resident physicians, parents, and community opioid addiction centers. Our specific goals would be to: 1) increase use and education about non-pharmacologic interventions, 2) simplify assessments of infants including use of simplified withdrawal score (rather than the Finnegan scoring system) particularly in infants > 8 days of life, 3) decrease duration and total daily dose of morphine given to infants, 4)Improve communication between hospital staff and families and empower mothers and care-takers of infants. We hope to improve the long-term outcomes of children as well as decrease overall healthcare costs. Our project also will be using similar techniques and measures a those published in a NIH funded QI effort from Yale. See Grossman MR et al. An initiative to improve the quality of care of infants with neonatal abstinence syndrome, Pediatrics, Vol 139, Number 6, June 2017.
QPI: Mary, Siebenaler, (firstname.lastname@example.org)
UF Health Big Aims: Increase Value None
MeSH Keywords: Neonatal Abstinence Syndrome, Opioid use, Drug withdrawal, Centering Care